News | News By Subject | News by Disease News By Date | Search News

Acne News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
RestorGenex (RESX) and Diffusion Pharma Merge to Form Wholly-Owned Oncology Subsidiary     12/28/2015
Novan Therapeutics to Build New Manufacturing Site for its Experimental Acne Treatments     10/28/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
FDA Approves Valeant (VRX)'s Onexton Gel For Acne Treatment     11/26/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
AbbVie (ABBV)'s Phase 3 Trial Of Humira Meets Primary Endpoint     9/12/2014
Valeant Pharmaceuticals International (VRX) Enters Into Patent Settlement Agreements With Actavis (ACT)     5/13/2014
FDA Approves Galderma Laboratories' Epiduo® to Treat Acne     2/20/2013
France Suspends Sales of Bayer AG (BAY.F)'s Acne Pill Diane 35 After Deaths     1/31/2013
Ranbaxy Laboratories (RANBAXY.BO) Gets FDA OK for Acne Treatment Absorica     5/29/2012
Galderma Laboratories Receives FDA Approval for New Convenient Pump Dispenser of Differin(R) Gel, 0.3% for Treatment of Acne Vulgaris     3/5/2012
Galderma Laboratories Received FDA Approval of Differin(R) (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation     3/22/2010
Roche Holding AG (RHHBF.PK) Ordered to Pay $25 Million to Accutane User     2/17/2010
Roche Holding AG (RHHBF.PK) Stops Selling Acne Drug Accutane     6/30/2009

News from Around the Web
Patients With Severe Acne Often Prescribed Ineffective Antibiotics, NYU Langone Medical Center Study     11/2/2015
Got Acne? Lay Off The B12, University of California, Los Angeles (UCLA) Study     6/25/2015
Acne Gel Linked To Rare Side Effect, University of Pittsburgh Medical Center Doctors Warn     2/2/2015
Popular Acne Products Can Be Dangerous, FDA Reveals     6/26/2014
Vitamin A Used In Acne Medicines May Help Autoimmune And Transplant Patients, Journal of Leukocyte Biology Reveals     1/31/2014
Sci-Fi Brought to Life as Spray Allows Scars to Heal Themselves, Sculpta Clinic Reveals     4/26/2011
Drug Resistance Not a Risk in Acne Treatment: University of Pennsylvania School of Medicine Study     4/12/2011
Early Success for Gel That Treats Acne Scars, New York University Study     2/9/2011
Acne Depression Link May Not be Due to Drugs: Oslo University Hospital Study     9/16/2010
Antibiotics Used to Combat Acne May Increase Inflammatory Bowel Disease Risk, University of Pennsylvania Study     8/23/2010
No Fracture Risk with Acne, Psoriasis Medications, Aarhus University Study     5/19/2010
Treat Acne with Coconut Oil and Nano-Bombs     4/15/2010
Silica Spheres Enhance Acne Drug, Sol-Gel Technologies Reports     5/26/2009
Acne Drug Linked To Depression, Centre Hospitalier Universitaire de Quebec Sainte-Justine Research Centre Study Shows     5/27/2008
Acne Drug Doxycycline Prevents Tissue Damage From Emphysema, Leeds University and University of California, San Diego (UCSD) Study     5/16/2008

Press Releases
AOBiome Expands Intellectual Property Estate, Announces Issuance Of U.S. Patent For Ammonia Oxidizing Bacteria (AOB) For The Treatment Of Acne     9/20/2017
Foamix Pharma (FOMX) Announces Dosing Of First Patient In Third Phase III Acne Study For Minocycline Foam FMX101     8/3/2017
BioPharmX Release: Summer AAD Panel To Discuss BPX-01 For Acne And Rosacea     7/27/2017
Regeneus (RGS.AX) U.S. Patent Allowed For Sygenus Secretions Technology For Acne     7/10/2017
BioPharmX Advances BPX-01 2% Upon Achieving Statistical Significance For Primary Endpoint     6/1/2017
BioPharmX Reports Positive Topline Results Of BPX-01 Topical Minocycline For Acne     5/4/2017
Foamix Pharma (FOMX) Announces Plans For Additional Phase III Trial For FMX101 In Moderate To Severe Acne     5/2/2017
Novan Presents Safety Data For SB204 Program     4/27/2017
Vyome Completes Enrollment For Proof Of Concept Clinical Study Of VB 1953 In Patients With Moderate To Severe Acne     4/25/2017
BioPharmX Completes Last Subject Visit In Its Phase IIb Trial Of BPX-01, Expects To Report Topline Results First Half Of May 2017     4/20/2017
Allergan (AGN) And Paratek Pharma (PRTK) Announce Positive Results From Two Phase III Trials Of Sarecycline For The Treatment Of Moderate To Severe Acne     3/27/2017
Foamix Pharma (FOMX) Craters As Acne Drug Flunks Phase III Test     3/27/2017
Xenon Pharmaceuticals Inc. Dumps Acne Drug After Trial Failure     3/24/2017
BioPharmX Society Of Toxicology Poster Suggests Promise Of BPX-01 As Topical Acne Therapy, Highlights Safety     3/13/2017
Vyome Announces Top-Line Results From Phase 1 Study Of VB-1953 For Patients With Facial Acne Vulgaris     2/7/2017